Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

WITHDRAWN

Cardiac Fibrosis by CMR in Patients With Cancer

Lead Sponsor:

Massachusetts General Hospital

Conditions:

Lymphoma

Eligibility:

All Genders

18+ years

Brief Summary

A study to test the effectiveness of an investigational imaging technique for detecting cardiac injury after the administration of certain chemotherapies, such as doxorubicin. "Investigational" means ...

Detailed Description

If you choose to take part in this study, we will ask you to sign this consent form before we do any study procedures. All participants will come in for a CMR scan prior to their first treatment with ...

Eligibility Criteria

Inclusion

  • Aged ≥ 18 and able to give consent
  • New diagnosis of lymphoma and scheduled to undergo doxorubicin (DOX)-based chemotherapy.

Exclusion

  • Concurrent radiotherapy prior to the performance of both CMR studies, however consolidative radiotherapy after the completion of DOX and after the acquisition of the second CMR study is acceptable
  • No prior malignancy treated with chemotherapy or mediastinal radiotherapy
  • No contraindications to the performance of a magnetic resonance study:
  • The presence of an implanted metallic object such as a cardiac pacemaker or implantable defibrillator
  • An implanted neural stimulator
  • Any ferromagnetic implants not deemed MRI-safe
  • Intra-ocular metallic foreign bodies
  • Severe claustrophobia
  • Pregnancy
  • Inability to perform an exercise test
  • Glomerular filtration rate \< 60 ml/min/1.73 m2

Key Trial Info

Start Date :

March 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 25 2018

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01906437

Start Date

March 1 2013

End Date

August 25 2018

Last Update

September 14 2018

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

2

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02215

3

Dana Farber Cancer Insitute

Boston, Massachusetts, United States, 02215